Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

27. November 2025 09:01 ET | Quelle: Research and Markets

DLL3-Targeted Immunotherapy Competitor Analysis Report 2025: The Field Still is in Mid-stage Clinical Development Without Clear Leader in the Competition

Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "DLL3-Targeted Immunotherapy: a Competitor Analysis" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence report...
26. August 2025 04:11 ET | Quelle: Research and Markets

Bispecific Antibody Drug Conjugates Clinical Trials and Competitive Landscape Report 2025 | Over 100 Bispecific ADCs Progressing in Clinical Trials

Dublin, Aug. 26, 2025 (GLOBE NEWSWIRE) -- The "Bispecific Antibody Drug Conjugates Clinical Trials, Development Platforms, Competitive Landscape & Market Opportunity Insight 2025" report has...
24. März 2025 06:08 ET | Quelle: Research and Markets

Bispecific Antibody Drug Conjugates (BsADCs) Market Outlook 2024-2029: Additional Candidates Undergo Clinical Studies and Become Commercially Available

Dublin, March 24, 2025 (GLOBE NEWSWIRE) -- The "Global Bispecific Antibody Drug Conjugates Research Outlook 2029" report has been added to ResearchAndMarkets.com's offering. Bispecific antibody...
14. Oktober 2024 05:52 ET | Quelle: Research and Markets

Bispecific Antibody Drug Conjugates Market Opportunity Outlook 2024-2029: China Leads Over 35 Candidates, Key Companies Pioneering BsADC are Amgen, Innovent Biologics, AstraZeneca

Dublin, Oct. 14, 2024 (GLOBE NEWSWIRE) -- The "Global Bispecific Antibody Drug Conjugates Clinical Trials, Regulatory Approvals & Future Market Opportunity Outlook 2029" report has been added to...